Evidence map›Paper›PMID 40520839›Full record

ArticleCureus2025

Management of Aggressive Acral Melanoma in a Pregnant Patient.

Leonard R Maier, Maria J Maier, Sharath Rajagopalan, David Shi, Vikash Kumar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leonard R MaierInternal Medicine, West Virginia University, Morgantown, USA.
Maria J MaierMedicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Sharath RajagopalanInternal Medicine, West Virginia University, Morgantown, USA.
David ShiInternal Medicine, West Virginia University, Morgantown, USA.
Vikash KumarInternal Medicine, West Virginia University, Morgantown, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acral melanoma is a rare and aggressive subtype of melanoma that arises on non-sun-exposed areas such as the soles, palms, and nail beds. It is often diagnosed at advanced stages and carries a poor prognosis. We present the case of a 28-year-old pregnant woman at 17 weeks gestation who developed a rapidly enlarging, ulcerated mass on the plantar aspect of her left foot. Biopsies confirmed acral lentiginous melanoma with extensive metastatic spread to the bones, liver, spleen, and lymph nodes. Immunohistochemical analysis was positive for MART-1, preferentially expressed antigen in melanoma (PRAME), and SOX10. After multidisciplinary counseling, the patient elected to terminate her pregnancy to initiate systemic immunotherapy. Despite treatment, her disease progressed rapidly, and she passed away shortly after the initiation of therapy. This case highlights the complexities of diagnosing and managing advanced melanoma in pregnancy and underscores the importance of the early recognition of atypical acral lesions, the limitations of treatment options during gestation, and the ethical challenges in balancing maternal and fetal health.

Indexed as

acral melanomafungating massmaternal cancermaternal-fetal medicinemetastatic melanomaoncology in pregnancypregnancy

Identifiers

PMID40520839
PMCPMC12165602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.